Coccetta M, Covarelli P, Cirocchi R, Boselli C, Santoro A, Cacurri A, Grassi V, Barillaro I, Koltraka B, Spizzirri A, Pressi E, Trastulli S, Gullà N, Noya G, Sciannameo F
Università Degli Studi Perudia Sade di Terri.
G Chir. 2010 Nov-Dec;31(11-12):556-9.
malignant tumors of the colon can metastases along the lymphatic system in a sequential way, which means that there will be a first node to be involved and then from this disease will pass to another node and so gradually. The sentinel lymph node is the first lymph node or group of nodes reached by metastasizing cancer cells from a tumor.
the present work aims to determine the predictive value of the sentinel lymph node procedure in the staging of non-metastatic colon cancer.
in this prospective study joined up only 26 patients with adenocarcinoma of the colon T2-T3, without systemic metastases, and with these criteria for inclusion: a) minimum age: 18 years old; b) staging by total colonoscopy, chest X-ray and CT scan; c) patients classified as ASA 1-3; d) informed consent. Within 20 minutes from the colic resection, the bowel was cut completely along the antimesenteric margin and is performed submucosal injection of vital dye within 5 mm from the lesion at the level of the four cardinal points; then the lymph nodes are placed in formalin and sent to the pathologist. The lymph nodes were subjected to histological examination with haematoxylin-eosin and with the immunohistochemistry technique.
from January to December 2008 only 26 patients joined up in this prospective study. From the study were excluded the 4 patients with T4 and M1 tumour. Also 7 patients with stenotic lesions were excluded. Patients considered eligible for our study were only 14. The histopathological examination of haematoxylin-eosin revealed: a) in 4 cases were detected mesocolic lymph node metastases; b) in 10 cases were not detected mesocolic lymph node metastases. In cases there were no metastases, the mesocolic sentinel lymph nodes lymph nodes were examined with immunohistochemical technique; in 2 cases were revealed the presence of micrometastases. In one case was identified aberrant lymphatic drainage patterns (skip metastasis); the sentinel lymph node (negative examination wit eaematoxylin-eosin) was studied with immunohistochemical technique that has not revealed the presence of micrometastases.
the examination of the sentinel node is feasible with the ex vivo method. Using the immunohistochemical technique we detect micrometastasis in 20% of the cases, not revealed with the classical haematoxylin-eosin examination. The study of sentinel lymph node with multilevel microsections and immunohistochemical techniques allow a better histopathological staging.
结肠癌恶性肿瘤可沿淋巴系统依次转移,这意味着会有首个受累淋巴结,随后疾病会逐渐转移至另一个淋巴结。前哨淋巴结是肿瘤转移癌细胞到达的首个淋巴结或淋巴结群。
本研究旨在确定前哨淋巴结活检术在非转移性结肠癌分期中的预测价值。
在这项前瞻性研究中,仅纳入了26例T2 - T3期结肠癌腺癌患者,无全身转移,纳入标准如下:a)最小年龄:18岁;b)通过全结肠镜检查、胸部X线和CT扫描进行分期;c)患者ASA分级为1 - 3级;d)签署知情同意书。在结肠切除术后20分钟内,沿系膜缘完全切断肠管,并在病变周围四个方位距病变5毫米处进行黏膜下活性染料注射;然后将淋巴结置于福尔马林中并送病理科医生检查。淋巴结进行苏木精 - 伊红染色组织学检查及免疫组织化学技术检查。
2008年1月至12月,仅有26例患者纳入该前瞻性研究。研究排除了4例T4和M1期肿瘤患者。另外7例有狭窄病变的患者也被排除。符合我们研究条件的患者仅14例。苏木精 - 伊红染色组织病理学检查显示:a)4例检测到结肠系膜淋巴结转移;b)10例未检测到结肠系膜淋巴结转移。在无转移的病例中,对结肠系膜前哨淋巴结进行免疫组织化学技术检查;2例发现存在微转移。1例发现异常淋巴引流模式(跳跃转移);对前哨淋巴结(苏木精 - 伊红染色检查为阴性)进行免疫组织化学技术检查,未发现微转移。
前哨淋巴结体外检查方法可行。使用免疫组织化学技术,我们在20%的病例中检测到了经典苏木精 - 伊红染色检查未发现的微转移。采用多层切片和免疫组织化学技术对前哨淋巴结进行研究可实现更好的组织病理学分期。